Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CKD Stage 2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03242018
What this trial is testing

Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease Stage 4
Lexicon Pharmaceuticals 277
Not applicableStudy completedNCT01279460
What this trial is testing

Aortic Stiffness in Chronic Kidney Disease Stage 2 to 4

Who this might be right for
Decline in Renal Function
Technical University of Munich 167
Testing effectiveness (Phase 2)WithdrawnNCT05599815
What this trial is testing

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Aldeyra Therapeutics, Inc.
Not applicableEnded earlyNCT01274117
What this trial is testing

Trial Comparing One-stage With Two-stage Basilic Vein Transposition

Who this might be right for
Brachiobasilic Arteriovenous Fistula
University of Patras 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05687890
What this trial is testing

Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseIgA Nephropathy
Biocity Biopharmaceutics Co., Ltd. 255
Post-approval studies (Phase 4)Study completedNCT02451917
What this trial is testing

Glargine Versus NPH in Patients With Chronic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
University of Sao Paulo General Hospital 34
Large-scale testing (Phase 3)Study completedNCT00542386
What this trial is testing

MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia+1 more
Tanabe Pharma Corporation 642
Not applicableNot Yet RecruitingNCT07579663
What this trial is testing

Personalized Two-stage Regional Citrate Anticoagulation for CRRT in Patients With Citrate Metabolism Impairment

Who this might be right for
AKI - Acute Kidney InjuryCKD 5D, HemodialysisHepatic Failure
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 142
Not applicableEnded earlyNCT01067963
What this trial is testing

Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency, Chronic
University of Colorado, Denver 80
Not applicableStudy completedNCT03383627
What this trial is testing

Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease

Who this might be right for
DiabetesKidney Diseases
Northwell Health 80
Testing effectiveness (Phase 2)Study completedNCT04724837
What this trial is testing

Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)

Who this might be right for
Chronic Kidney Disease
AstraZeneca 542
Not applicableStudy completedNCT01102179
What this trial is testing

Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease (CKD) Patients in Singapore

Who this might be right for
Stage 2-5 Chronic Kidney DiseasePredialysis
National University of Singapore 196
Testing effectiveness (Phase 2)Study completedNCT02044653
What this trial is testing

Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)

Who this might be right for
AnemiaChronic Kidney Disease
Genexine, Inc. 257
Testing effectiveness (Phase 2)Ended earlyNCT01574365
What this trial is testing

RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Kyowa Kirin Co., Ltd. 53
Testing effectiveness (Phase 2)Study completedNCT01414114
What this trial is testing

Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 37
Not applicableActive Not RecruitingNCT07830030
What this trial is testing

Metabolic Status and Risk of Chronic Kidney Disease in French Overseas Populations With Morbid Obesity (OBECAMcohort).

Who this might be right for
Morbid ObesityChronic Kidney Disease (Stage 3-4)
Clinique 480
Testing effectiveness (Phase 2)Ended earlyNCT01113801
What this trial is testing

A Study in Participants With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetic Glomerulosclerosis
Eli Lilly and Company 417
Not applicableLooking for participantsNCT07518719
What this trial is testing

Feasibility of The Health Integrated Nutrition and Kidney Wellness Program

Who this might be right for
Chronic Kidney DiseaseCardiovascular Disease
University of Pittsburgh 45
Large-scale testing (Phase 3)Study completedNCT01698775
What this trial is testing

Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 213
Large-scale testing (Phase 3)Looking for participantsNCT03969329
What this trial is testing

Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Amgen 24
Next Page